跳至主要内容
临床试验/NCT03498742
NCT03498742已完成不适用

Asthmatic Subjects Could Live Without Short Acting Beta2 Agonists (SABA)

Universidad Nacional de Rosario1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2017年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
86
试验地点
1
主要终点
Asthma Control Test

研究概览

简要总结

Since 2006 there was a plateau in world wide mortality from asthma. Overreliance in Short Acting Beta2 Agonists (SABA) was associated with increased risk of death from asthma. Long acting beta agonists (LABA) alone was not permitted as treatment for asthma as it was determined by FDA by the "black box". By contrast SABA does not have a "black box", despite similar overuse alerts associated with increased risk of death from asthma. the investigators want to know if exist asthmatic subjects that do use another rescue medication; not SABA, and to compare their features, Asthma Control Test (ACT), and lung function in a outpatient facility.

First consecutive visits at outpatient Pulmonary Section of asthmatic subjects were described. Asthma Control Test (ACT) that was routinely used to assess asthma and spirometry were performed.

详细描述

During the period from March 10, 2017 to January 16, 2018 the investigators decided to describe the rescue medication in all new asthmatic subjects that came for a first visit to the outpatient pulmonary department. Patients aged ≥16 years were entered in the study with a a diagnosis of asthma, based on a history of episodic dyspnea and wheezing, and/or documented bronchodilator reversibility in forced expiratory volume in 1 s (FEV1) of 12% and 200 ml according to the National Institutes of Health criteria; to be non- or ex-smoker of less than 10 pack-yr, to be neither pregnant nor breast-feeding and to be capable of completing Asthma control test and spirometry. Consecutive patients visiting the outpatient pulmonary department were included in the description.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
16 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of asthma, based on a history of episodic dyspnea and wheezing, and/or documented bronchodilator reversibility in forced expiratory volume in 1 s (FEV1) of 12% and 200 ml according to the National Institutes of Health criteria;
  • to be non- or ex-smoker of less than 10 pack-yr,
  • to be neither pregnant nor breast-feeding
  • to be capable of completing Asthma control test and spirometry. -

排除标准

  • Any other pulmonary disorder than asthma. Illiteracy.

结局指标

主要结局

Asthma Control Test

时间窗: One year

Score less than 16 indicates Poorly controlled asthma. Score \>19 indicates well controlled asthma.

次要结局

  • Acute asthma attack requiring Hospitalization and/or Emergency Room visits in the last 12 months(One year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

HEEP UNR

Pulmonologist in Chief Pulmonary Section HEEP

Universidad Nacional de Rosario

研究点 (1)

Loading locations...

相似试验

Asthmatic Subjects Could Live Without Short Acting... | 临床试验